Tactile Systems Technology (TCMD) Capital Expenditures (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Tactile Systems Technology | 539.21 Mn | 449.02 Mn | 57.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.98% |
| Dec 31, 2025 | -54.55% |
| Sep 30, 2025 | 204.07% |
| Jun 30, 2025 | -2.64% |
| Mar 31, 2025 | -17.61% |
| Dec 31, 2024 | -51.58% |
| Sep 30, 2024 | 90.00% |
| Jun 30, 2024 | 3.73% |
| Mar 31, 2024 | -46.44% |
| Dec 31, 2023 | 136.22% |
| Sep 30, 2023 | -52.49% |
| Jun 30, 2023 | 232.78% |
| Mar 31, 2023 | 391.84% |
| Dec 31, 2022 | -96.50% |
| Sep 30, 2022 | 600.00% |
| Jun 30, 2022 | 52.67% |
| Mar 31, 2022 | -85.15% |
| Dec 31, 2021 | 42.72% |
| Sep 30, 2021 | 74.58% |
| Jun 30, 2021 | 42.17% |
| Mar 31, 2021 | -42.89% |
| Dec 31, 2020 | -54.72% |
| Sep 30, 2020 | 218.87% |
| Jun 30, 2020 | -15.64% |
| Mar 31, 2020 | -69.40% |
| Dec 31, 2019 | -53.50% |
| Sep 30, 2019 | 144.51% |
| Jun 30, 2019 | 40.77% |
| Mar 31, 2019 | -59.66% |
| Dec 31, 2018 | 164.91% |
| Sep 30, 2018 | -46.06% |
| Jun 30, 2018 | 193.52% |
| Mar 31, 2018 | -75.91% |
| Dec 31, 2017 | 310.30% |
| Sep 30, 2017 | -46.45% |
| Jun 30, 2017 | 16.57% |
| Mar 31, 2017 | 172.37% |
| Dec 31, 2016 | 24.76% |
| Sep 30, 2016 | 3.00% |
| Jun 30, 2016 | 78.57% |
| Mar 31, 2016 | -34.88% |
| Dec 31, 2015 | 8.18% |